US pharmaceutical packaging specialist Packaging Coordinators Inc (PCI) has added Tadataka Yamada to its Board of Directors.
Dr Yamada recently rejoined Frazier Healthcare, a principal owner of PCI, as a Venture Partner on the Life Sciences team.
Prior to this role, Yamada was Chief Medical and Scientific Officer at Takeda Pharmaceuticals in Tokyo, as well as serving on the Takeda Board of Directors.
He has also served as President of the Bill & Melinda Gates Foundation Global Health Program, in addition to having been Chairman of Research and Development at GlaxoSmithKline, where he was also a member of the Board of Directors.
PCI's President and CEO Bill Mitchell said: 'We could not be more pleased to have someone of Dr Tadataka Yamada’s intelligence and experience join our Board of Directors.
'He brings a level of insight and practical experience that is truly invaluable as we continue to expand the breadth of our service offering to our clients. Our ongoing strategy is to align our portfolio of services to truly meet our client needs as part of a strategic outsourcing partnership. Dr Yamada understands the pharmaceutical and biotech industry better than anyone. His presence and guidance is a tremendous asset for PCI.'
